Cargando…

Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases

Background and Objectives: The impact of the duration of symptoms (DOS) on postoperative clinical outcomes of patients with degenerative lumbar spinal diseases is important for determining the optimal timing of surgical intervention; however, the timing remains controversial. This prospective case–c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiranaka, Yoshiaki, Miyazaki, Shingo, Yurube, Takashi, Kuroshima, Kohei, Ryu, Masao, Inoue, Shinichi, Kakutani, Kenichiro, Tadokoro, Ko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867228/
https://www.ncbi.nlm.nih.gov/pubmed/36676647
http://dx.doi.org/10.3390/medicina59010022
_version_ 1784876290167275520
author Hiranaka, Yoshiaki
Miyazaki, Shingo
Yurube, Takashi
Kuroshima, Kohei
Ryu, Masao
Inoue, Shinichi
Kakutani, Kenichiro
Tadokoro, Ko
author_facet Hiranaka, Yoshiaki
Miyazaki, Shingo
Yurube, Takashi
Kuroshima, Kohei
Ryu, Masao
Inoue, Shinichi
Kakutani, Kenichiro
Tadokoro, Ko
author_sort Hiranaka, Yoshiaki
collection PubMed
description Background and Objectives: The impact of the duration of symptoms (DOS) on postoperative clinical outcomes of patients with degenerative lumbar spinal diseases is important for determining the optimal timing of surgical intervention; however, the timing remains controversial. This prospective case–control study aimed to investigate the influence of the preoperative DOS on surgical outcomes in minimally invasive surgery-transforaminal lumbar interbody fusion (MIS-TLIF). Materials and Methods: Patients who underwent single-level TLIF for lumbar degenerative diseases between 2017 and 2018 were reviewed. Only patients with full clinical data during the 1-year follow-up period were included. The patients were divided into two groups (DOS < 12 months, group S; DOS ≥ 12 months, group L). The clinical outcomes, including the Oswestry disability index (ODI) and visual analog scale (VAS) for lower back pain, leg pain, and numbness, were investigated preoperatively and at 1, 3, and 6 months, as well as 1 year, after surgery. Furthermore, postoperative patient satisfaction 1 year after surgery was also surveyed. Results: A total of 163 patients were assessed: 60 in group S and 103 in group L. No differences in baseline characteristics and clinical outcomes were found. The ODI and VAS significantly improved from the baseline to each follow-up period (all p < 0.01). Group S had significantly lower ODI scores at 3 months (p = 0.019) and 6 months (p = 0.022). In addition, group S had significantly lower VAS scores for leg pain at 3 months (p = 0.027). In a comparison between both groups, only the patients with cauda equina symptoms showed that ODI and leg pain VAS scores at 3 months after surgery were significantly lower in group S (19.9 ± 9.1 vs. 14.1 ± 12.5; p = 0.037, 7.4 ± 13.9 vs. 14.7 ± 23.1; p = 0.032, respectively). However, the clinical outcomes were not significantly different between both groups 1 year after surgery. Patient satisfaction was also not significantly different between both groups. Conclusions: Patients with a shorter DOS tended to have a significantly slower recovery; however, clinical outcomes 1 year after surgery were good, regardless of the DOS.
format Online
Article
Text
id pubmed-9867228
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98672282023-01-22 Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases Hiranaka, Yoshiaki Miyazaki, Shingo Yurube, Takashi Kuroshima, Kohei Ryu, Masao Inoue, Shinichi Kakutani, Kenichiro Tadokoro, Ko Medicina (Kaunas) Article Background and Objectives: The impact of the duration of symptoms (DOS) on postoperative clinical outcomes of patients with degenerative lumbar spinal diseases is important for determining the optimal timing of surgical intervention; however, the timing remains controversial. This prospective case–control study aimed to investigate the influence of the preoperative DOS on surgical outcomes in minimally invasive surgery-transforaminal lumbar interbody fusion (MIS-TLIF). Materials and Methods: Patients who underwent single-level TLIF for lumbar degenerative diseases between 2017 and 2018 were reviewed. Only patients with full clinical data during the 1-year follow-up period were included. The patients were divided into two groups (DOS < 12 months, group S; DOS ≥ 12 months, group L). The clinical outcomes, including the Oswestry disability index (ODI) and visual analog scale (VAS) for lower back pain, leg pain, and numbness, were investigated preoperatively and at 1, 3, and 6 months, as well as 1 year, after surgery. Furthermore, postoperative patient satisfaction 1 year after surgery was also surveyed. Results: A total of 163 patients were assessed: 60 in group S and 103 in group L. No differences in baseline characteristics and clinical outcomes were found. The ODI and VAS significantly improved from the baseline to each follow-up period (all p < 0.01). Group S had significantly lower ODI scores at 3 months (p = 0.019) and 6 months (p = 0.022). In addition, group S had significantly lower VAS scores for leg pain at 3 months (p = 0.027). In a comparison between both groups, only the patients with cauda equina symptoms showed that ODI and leg pain VAS scores at 3 months after surgery were significantly lower in group S (19.9 ± 9.1 vs. 14.1 ± 12.5; p = 0.037, 7.4 ± 13.9 vs. 14.7 ± 23.1; p = 0.032, respectively). However, the clinical outcomes were not significantly different between both groups 1 year after surgery. Patient satisfaction was also not significantly different between both groups. Conclusions: Patients with a shorter DOS tended to have a significantly slower recovery; however, clinical outcomes 1 year after surgery were good, regardless of the DOS. MDPI 2022-12-22 /pmc/articles/PMC9867228/ /pubmed/36676647 http://dx.doi.org/10.3390/medicina59010022 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hiranaka, Yoshiaki
Miyazaki, Shingo
Yurube, Takashi
Kuroshima, Kohei
Ryu, Masao
Inoue, Shinichi
Kakutani, Kenichiro
Tadokoro, Ko
Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases
title Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases
title_full Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases
title_fullStr Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases
title_full_unstemmed Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases
title_short Influence of the Preoperative Duration of Symptoms on Patients’ Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases
title_sort influence of the preoperative duration of symptoms on patients’ clinical outcomes after minimally invasive surgery-transforaminal lumbar interbody fusion for degenerative lumbar spinal diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867228/
https://www.ncbi.nlm.nih.gov/pubmed/36676647
http://dx.doi.org/10.3390/medicina59010022
work_keys_str_mv AT hiranakayoshiaki influenceofthepreoperativedurationofsymptomsonpatientsclinicaloutcomesafterminimallyinvasivesurgerytransforaminallumbarinterbodyfusionfordegenerativelumbarspinaldiseases
AT miyazakishingo influenceofthepreoperativedurationofsymptomsonpatientsclinicaloutcomesafterminimallyinvasivesurgerytransforaminallumbarinterbodyfusionfordegenerativelumbarspinaldiseases
AT yurubetakashi influenceofthepreoperativedurationofsymptomsonpatientsclinicaloutcomesafterminimallyinvasivesurgerytransforaminallumbarinterbodyfusionfordegenerativelumbarspinaldiseases
AT kuroshimakohei influenceofthepreoperativedurationofsymptomsonpatientsclinicaloutcomesafterminimallyinvasivesurgerytransforaminallumbarinterbodyfusionfordegenerativelumbarspinaldiseases
AT ryumasao influenceofthepreoperativedurationofsymptomsonpatientsclinicaloutcomesafterminimallyinvasivesurgerytransforaminallumbarinterbodyfusionfordegenerativelumbarspinaldiseases
AT inoueshinichi influenceofthepreoperativedurationofsymptomsonpatientsclinicaloutcomesafterminimallyinvasivesurgerytransforaminallumbarinterbodyfusionfordegenerativelumbarspinaldiseases
AT kakutanikenichiro influenceofthepreoperativedurationofsymptomsonpatientsclinicaloutcomesafterminimallyinvasivesurgerytransforaminallumbarinterbodyfusionfordegenerativelumbarspinaldiseases
AT tadokoroko influenceofthepreoperativedurationofsymptomsonpatientsclinicaloutcomesafterminimallyinvasivesurgerytransforaminallumbarinterbodyfusionfordegenerativelumbarspinaldiseases